news
GSK reported to have started the sale of $1.2 billion consumer health drugs
According to Reuters, GSK has started the sale of some consumer health brands as it seeks to raise £1 billion.
List view / Grid view
Mergers & Acquisitions
news
New partnership established to develop an innovation lab
Google and Sanofi have partnered to develop an innovation lab for the advancement of health services.
news
New initiative launched to boost Northern Ireland’s life science industry
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
news
Collaboration to produce new clinical stage TB drug candidates
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded TB Alliance a CETR grant for tuberculosis drug development.
news
Sanofi to acquire haemophilia specialists Bioverativ for $11.6bn
Sanofi and Bioverativ Inc., have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ...
news
EC approves first biosimilar Mvasi for the treatment of cancer
The European Commission has granted marketing authorisation for Mvasi for the treatment of certain types of cancer...
news
Medtech sales to reach $522bn by 2022
EvaluateMedTech World Preview provides a range of insights into the expected performance of the medtech industry...
news
Bluebird bio joins the ABPI as a full member
The Association of the British Pharmaceutical Industry (ABPI) has admitted the American biotech bluebird bio, Inc. as a full member...
news
Codes of ethics cause problems for overseas operations
Corporate codes of ethics can have reverse effects and mask anomalies or social evils in operations outsourced to low-wage countries...
news
Agilent Technologies acquires raman spectroscopy innovator, Cobalt Light Systems
Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers...
article
Outsourcing: Current trends in the CDMO sector
Patheon’s Joe Principe examines current trends in outsourcing, highlighting the importance of investment in CDMO partnerships...
news
Collaboration is ‘game changer’ in delivering cell and gene therapies
Collaboration between the pharmaceutical industry, patients and health regulators will be a ‘game changer’ in delivering exciting new cell and gene therapies to treat conditions like cancer and vision loss.
news
Thermo Fisher to acquire Patheon in $7.2bn deal
Thermo Fisher Scientific announced yesterday that it would buy contract development and manufacturing organisation (CDMO) Patheon for $7.2bn...
news
Thermo Fisher Scientific acquires Core Informatics
Thermo Fisher Scientific Inc., the world leader in serving science, announced that it has acquired Core Informatics, which provides a leading cloud-based platform supporting scientific data management.
news
French drug developer Ethypharm acquires UK-based Martindale Pharma
Ethypharm has signed a definitive agreement to acquire Martindale Pharma.
